LB Pharmaceuticals Appoints Joseph Miller as CFO
LB Pharmaceuticals (LBRX) announced the appointment of Joseph Miller as its new chief financial officer. Prior to joining LBRX, Miller held several leadership roles in finance at companies such as Aurinia Pharmaceuticals and Avalo Therapeutics. He also served as vice president of finance at Sucampo Pharmaceuticals and has experience with QIAGEN, Eppendorf, and KPMG LLP. The announcement came on Thursday, and shares of LB Pharmaceuticals rose nearly 5% in pre-market trading following the news. The hiring reflects a strategic move to strengthen financial leadership as the company continues its operations.
Tickers: $LBRX
Topics: CFO Hire Leadership Change